P2Y Receptor
All Product Categories
-
P2Y Receptor Inhibitors
(42)
View all products
-
P2Y Receptor Agonists
(22)
View all products
-
P2Y Receptor Antagonists
(34)
View all products
-
P2Y Receptor Activators
(4)
View all products
-
P2Y Receptor Modulators
(2)
View all products
-
P2Y Receptor Controls
(3)
View all products
-
P2Y Receptor Ligands
(2)
View all products
-
P2Y Receptor Related Products (121)
Related Products (121)
-
Prasugrel hydroxy thiolactone
0 ImagesCat. No.: HY-W686186CAS No.: 947502-66-1
-
Gαq/11 protein-IN-2
0 ImagesCat. No.: HY-179165Gαq/11 protein-IN-2 (Compound 9g) is a Gαq/11 protein inhibitor, with an IC50 of 11.3 μM. Gαq/11 protein-IN-2 induces Apoptosis, increases p-YAP. Gαq/11 protein-IN-2 has anticancer activity against uveal melanoma.
-
P2ry1 Mouse Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09915P2ry1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for P2ry1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
MRS2957
0 ImagesCat. No.: HY-108664CAS No.: 1228271-30-4MRS2957 is a P2Y6 receptor agonist that activates AMPK in pancreatic β-cells, promoting insulin secretion and reducing apoptosis, thereby holding potential as a therapeutic target for type 2 diabetes.
-
Prasugrel (Standard)
0 ImagesSynonyms: PCR 4099 (Standard)Prasugrel (Standard) is the analytical standard of Prasugrel. This product is intended for research and analytical applications. Prasugrel (PCR 4099), a thienopyridine and proagent, inhibits platelet function. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation.
-
P2Y2R antagonist 1
0 ImagesCat. No.: HY-179448CAS No.: 3120348-70-8P2Y2R antagonist 1 is a selective P2Y2R antagonist (pIC50 = 7.78). P2Y2R antagonist 1 can be used for the study of Glioma.
-
Prasugrel-13C6
0 ImagesCat. No.: HY-15284S3CAS No.: 1261394-83-5Synonyms: PCR 4099-13C6Prasugrel-13C6 is a deuterated labeled Prasugrel. Prasugrel (PCR 4099), a thienopyridine and proagent, inhibits platelet function. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation.
-
P2RY12 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09919P2RY12 Human Pre-designed siRNA Set A contains three designed siRNAs for P2RY12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
mrs 4062 TEA
0 ImagesCat. No.: HY-110089CAS No.: 1309871-50-8mrs 4062 (TEA) is a selective P2Y4 receptor agonist with an EC50 of 23 nM. mrs 4062 (TEA) has EC50s of 640 nM and 740 nM for P2Y2 and P2Y6, respectively.
-
Chloramphenicol succinate
0 ImagesChloramphenicol succinate is a prodrug of Chloramphenicol (HY-B0239), acting as a P2Y14R inhibitor with an IC50 of 1.585 nM. Chloramphenicol succinate serves as a competitive substrate and inhibitor of succinate dehydrogenase (SDH), which may account for its toxicity. Chloramphenicol succinate exerts a significant inhibitory effect on colitis. Chloramphenicol succinate can be used in research related to myelosuppression, gray baby syndrome, aplastic anemia, bacterial meningitis and inflammatory bowel disease.
-
Uridine 5'-diphosphate sodium
0 ImagesCat. No.: HY-W1058220CAS No.: 19817-91-5Synonyms: UDP sodiumUridine-5'-diphosphate (UDP) sodium is an important nucleotide made of uracil, ribose, and a pyrophosphate group. Uridine-5'-diphosphate sodium is a potent, selective human P2Y6 receptor native agonist (EC50 = 300 nM; pEC50 = 6.52). Uridine-5'-diphosphate sodium, an endogenous metabolite, catalyzes the glucuronidation of a wide array of substrates and is used in nucleic acid (RNA) biosynthesis.
-
P2ry2 Rat Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09930P2ry2 Rat Pre-designed siRNA Set A contains three designed siRNAs for P2ry2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
P2ry4 Mouse Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09932P2ry4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for P2ry4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
Rp-dUTPαS tetrasodium
0 ImagesCat. No.: HY-137616CRp-dUTPαS (tetrasodium) is an isomer of the sulfur-containing nucleoride dUTP-α-S and an agonist of the purinergic P2Y2 receptor. Rp-dUTPαS (tetrasodium) selectively induces inositol phosphate accumulation in P2Y2-expressing 1321N1 cells with an EC50 of 12.5 μM.
-
Clopidogrel-13C,d3 sulfate
0 ImagesCat. No.: HY-107867S2CAS No.: 1246814-55-0Clopidogrel-13C,d3 sulfate is the deuterium and 13C-labeled (±)-Clopidogrel (bisulfate) (HY-107867). (±)-Clopidogrel bisulfate is a platelet P2Y12 receptor inhibitor and an adenosine diphosphate (ADP) receptor antagonist. (±)-Clopidogrel bisulfate inhibits the binding of ADP to its receptors on the membranes of platelet cells, and blocks ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. (±)-Clopidogrel bisulfate reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. (±)-Clopidogrel bisulfate has anti-inflammatory effects.
-
(±)-Clopidogrel-d4
0 ImagesSynonyms: (±)-Clopidogrelum-d4(±)-Clopidogrel-d4 ((±)-Clopidogrelum-d4) is the deuterium labeled (±)-Clopidogrel (HY-107867). (±)-Clopidogrel is a platelet P2Y12 receptor inhibitor and an adenosine diphosphate (ADP) receptor antagonist. (±)-Clopidogrel inhibits the binding of ADP to its receptors on the membranes of platelet cells, and blocks ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. (±)-Clopidogrel reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. (±)-Clopidogrel has anti-inflammatory effects.
-
2-Methylthio-AMP sodium
0 ImagesCat. No.: HY-103064CAS No.: 81921-45-12-Methylthio-AMP sodium is a selective and direct P2Y12 antagonist. 2-Methylthio-AMP sodium is an inhibitor of ADP-dependent platelet aggregation.
-
MRS2690 disodium
0 ImagesCat. No.: HY-116295AMRS2690 disodium is a selective P2Y14 receptor agonist. MRS2690 disodium inhibits adenylyl cyclase activity, thereby reducing intracellular cAMP levels and mediating concentration-dependent vasoconstriction of porcine coronary arteries. MRS2690 disodium induces intracellular calcium mobilization, activates P38 and stimulates [35S]GTPγS binding to RBL-2H3 cell membranes. MRS2690 enhances antigen (NP-BSA)-, C3a-induced β-hexosaminidase (β-Hex) release. MRS2690 disodium can be used for ischemic heart disease.
